Celcuity (CELC) Shares Issued (2017 - 2026)
Celcuity's (CELC) quarterly Shares Issued came in at $2.7 million in Q4 2025, down 36.36% YoY from $4.3 million in Q4 2024, and down 4.31% on a QoQ basis from $2.9 million in Q3 2025.
Celcuity (CELC) Shares Issued (2017 - 2026) Analysis & Trends
Celcuity (CELC) has 9 years of Shares Issued data on file, last reported at $2.7 million in Q4 2025.
- Quarterly Shares Issued fell 36.36% year-over-year to $2.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.7 million (down 36.36% YoY) and the FY2025 annual result came in at $2.7 million, down 36.36% from the prior year.
- Shares Issued fell to $2.7 million in Q4 2025, from $2.9 million in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $4.3 million in Q4 2024 to a low of $504189.0 in Q2 2021.
- A 5-year average of $2.1 million and a median of $1.9 million in 2022 frame the typical range for Shares Issued.
- Annual changes were most pronounced in 2022 — Shares Issued soared 253.59% — and 2025, when it plunged 36.36%.
- Tracing CELC's Shares Issued over 5 years: stood at $1.3 million in 2021, then soared by 50.27% to $2.0 million in 2022, then surged by 42.44% to $2.8 million in 2023, then surged by 52.98% to $4.3 million in 2024, then sank by 36.36% to $2.7 million in 2025.
- The last three Shares Issued figures came in at $2.7 million (Q4 2025), $2.9 million (Q3 2025), and $2.3 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 18.36 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Celcuity | 4.50 Bn | 4.50 Bn | - | 5.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.54 Mn |
| Jun 30, 2026 | 5.54 Mn |
| Dec 31, 2025 | 2.74 Mn |
| Dec 31, 2025 | 2.74 Mn |
| Sep 30, 2025 | 2.86 Mn |
| Sep 30, 2025 | 2.86 Mn |
| Jun 30, 2025 | 2.35 Mn |
| Jun 30, 2025 | 2.35 Mn |
| Mar 31, 2025 | 1.01 Mn |
| Mar 31, 2025 | 1.01 Mn |
| Dec 31, 2024 | 4.31 Mn |
| Dec 31, 2024 | 4.31 Mn |
| Sep 30, 2024 | 4.21 Mn |
| Sep 30, 2024 | 4.21 Mn |
| Jun 30, 2024 | 3.27 Mn |
| Jun 30, 2024 | 3.27 Mn |
| Mar 31, 2024 | 1.57 Mn |
| Mar 31, 2024 | 1.57 Mn |
| Dec 31, 2023 | 2.82 Mn |
| Dec 31, 2023 | 2.82 Mn |